Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytomegalovirus infections.

Mohamad Khoshnevis1, Stephen K Tyring

  • 1Department of Internal Medicine, Baylor College of Medicine, Houston, TX 79030, USA.

Dermatologic Clinics
|July 18, 2002
PubMed
Summary

Human cytomegalovirus (HCMV) is a significant pathogen in immunocompromised patients, particularly after transplantation or with AIDS. This review covers HCMV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Switching to ustekinumab biosimilars for plaque psoriasis: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Exosomes in Dermatology.

Skin therapy letter·2026
Same author

Enhanced Home-Based Wart Treatment Protocol: Optimizing Debridement and Occlusion Therapy for Improved Outcomes.

Advances in skin & wound care·2026
Same author

Herpes Zoster Risk in the Era of Targeted Immunotherapy: JAK Inhibitors Versus Biologics.

Journal of cutaneous medicine and surgery·2026
Same author

Acquired Epidermodysplasia Verruciformis in Patients with Iatrogenic Immunosuppression.

Journal of clinical medicine·2026
Same author

A novel oral interleukin-23 receptor antagonist peptide, icotrokinra, for moderate-to- severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.

Inflammopharmacology·2026

Area of Science:

  • Virology
  • Immunology
  • Dermatology

Background:

  • Increased immunosuppressive therapy post-transplantation and rising AIDS incidence have elevated human cytomegalovirus (HCMV) significance.
  • HCMV, a herpesviridae family member, establishes latency in myeloid cells with reactivation potential.
  • The natural history includes primary infection, latency, and reinfection.

Purpose of the Study:

  • To review the molecular pathogenesis of HCMV.
  • To focus on the clinical manifestations of HCMV infection, particularly skin pathology.
  • To discuss diagnostic methods and treatments for HCMV.

Main Methods:

  • Review of existing literature on HCMV molecular pathogenesis, clinical presentation, diagnosis, and treatment.
  • Emphasis on dermatological manifestations of HCMV infection.
  • Synthesis of information regarding HCMV in immunocompromised and immunocompetent individuals.

Main Results:

  • HCMV is a major pathogen in immunocompromised populations.
  • Skin pathology is a significant clinical manifestation of HCMV infection.
  • Various diagnostic and therapeutic strategies are available.

Conclusions:

  • HCMV poses a substantial clinical challenge, especially in immunocompromised patients.
  • Understanding HCMV pathogenesis and clinical spectrum, including skin involvement, is crucial for effective management.
  • Continued research into diagnostics and treatments is warranted.

Related Experiment Videos